← Open Payments lookup

BENJAMIN YEBOAH: Open Payments

NPI 1174705636 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 28 payments from 14 companies in 2025. Trend: 2023 $319 · 2024 $567 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
Novo Nordisk Inc6$235
Lundbeck LLC5$109
Astellas Pharma US Inc3$83
AstraZeneca Pharmaceuticals LP3$69
ABBVIE INC.2$43
Inspire Medical Systems, Inc.1$27
Neurocrine BioSciences, Inc.1$26
Baxter Healthcare1$25
Novartis Pharmaceuticals Corporation1$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23

Products named: Wegovy, REXULTI, Veozah, VRAYLAR, INSPIRE, INGREZZA, Hillrom - Carnation Ambulatory Monitor, LEQVIO.

Industry payments across CT — which companies pay providers there.